Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 8, 2010 Brian Orelli	Surprise Us in a Good Way, Merck Keeping up productivity during plant closures won't be easy.
The Motley Fool May 6, 2008 Brian Orelli	A Sign of the Pharma Times Merck is the latest big pharma cutting jobs to improve its bottom line.
The Motley Fool February 2, 2011 Brian Orelli	Pfizer's Newest Acquisition Target The pharma giant decided to cut potential acquisitions from its revenue guidance and instead spend the money on share buybacks.
The Motley Fool March 18, 2009 Brian Orelli	Merck Pummels Pfizer One of these acquisitions is not like the other.
The Motley Fool August 18, 2010 Jordan DiPietro	How Long Will Merck's Dividend Last? Check out how Merck stacks up in this article.
The Motley Fool March 9, 2009 Brian Orelli	Merck-Schering Trumps Pfizer-Wyeth The new Merck deal looks a lot better than a combined Pfizer plus Wyeth.
The Motley Fool April 25, 2011 Brian Orelli	Dividend Investors Rejoice! Or Not. Amgen establishes a dividend, investors yawn.
The Motley Fool October 30, 2009 Brian Orelli	World's Scariest Stocks: Pfizer For Pfizer, the big, scary unknown comes from whether it can integrate its recent acquisition of Wyeth.
The Motley Fool December 13, 2011 Brian Orelli	Dividend? Buyback? Here's How to Get Both. But will there be enough to replenish the pipeline?
The Motley Fool April 21, 2009 Brian Orelli	Schering and Merck: A Match Made in Purgatory Until Merck can show that it's capable of growing sales again, investors should be leery of stepping in, even with the dividend yield pushing 6%.
Chemistry World August 3, 2011 Patrick Walter	Merck Continues Restructuring and Cuts 13,000 Jobs US drug giant Merck & Co will lay off as much as 13 per cent of its workforce - up to 13,000 staff - by the end of 2015. The move is part of an aggressive cost cutting drive to streamline the company.
Chemistry World February 18, 2010 Matt Wilkinson	Merck joins the cost-cutting crowd Following its merger with Schering-Plough, US drug giant Merck & Co. has announced a 'merger restructuring plan' that in its first phase will see 17,500 jobs cut.
The Motley Fool June 8, 2011 Brian Orelli	Blockbuster Drug-Like Profits, No FDA Required Pfizer keeps the cuts coming.
The Motley Fool October 22, 2008 Brian Orelli	Merck's a Bloated Garbage Heap of Stale Drugs Now Merck is planning on cutting 12% of its workforce in the hopes of saving $4 billion through 2013.
The Motley Fool June 23, 2005 Rich Smith	Dueling Fools: Merck Bull It's hard to argue with a price this cheap. With a price-to-free cash flow ratio of less than 11, Merck's a steal.
The Motley Fool December 5, 2008 Brian Orelli	Good Luck in 2010, Merck It's not just one problem for Merck, but a whole series of issues that have turned the company into a heap of stale drugs.
The Motley Fool August 13, 2010 Ilan Moscovitz	Merck: Dividend Dynamo or Disaster? Just how safe is this dividend?
The Motley Fool February 29, 2008 Brian Orelli	2007 Pharma Roundup How did big pharma do in 2007? With the drug sector earnings season winding down, now seems like a good time to take a look at how they fared and, more importantly, where they're headed.
The Motley Fool April 28, 2009 Brian Orelli	The Costs of Being Pfizer With Pfizer having announced its intention to buy Wyeth this quarter, investors may have worried that the negotiating and pre-acquisition planning caused management to be distracted, but that doesn't seem to be the case.
The Motley Fool October 24, 2011	A Brief History of Pfizer's Returns At 14 times earnings, Pfizer looks reasonably valued, but not exactly cheap.
The Motley Fool February 3, 2011 Brian Orelli	Get Ready for Merck's Bumpy Ride Long-term earnings guidance gets thrown out the window.
The Motley Fool August 26, 2010 Jordan DiPietro	Pfizer's Dividends May Not Last Forever Pfizer, which operates in the pharmaceuticals industry, currently pays a dividend of 4.5%. But what's more important than the dividend itself is Pfizer's ability to keep that that cash rolling.
The Motley Fool December 20, 2006 Selena Maranjian	Buy Tomorrow's Big Yields Today Before it's too late, snap up a future 20% yield. The key is finding companies that have the fiscal strength to raise their dividend year after year. And they're out there.
The Motley Fool February 16, 2010 Brian Orelli	Merck Gets a Pass, for Now Its first quarter looks promising, but not as good as could be hoped.
The Motley Fool January 26, 2007 Selena Maranjian	What Dividends Tell You Dividends can tell you a lot about a company -- perhaps more than you think.
The Motley Fool December 21, 2006 Brian Lawler	Dueling Fools: Merck Bull What you are getting with Merck is one of the best-managed pharmas out there that will be experiencing solid double-digit earnings growth in the not-too-distant future with a smart dividend payout.
The Motley Fool November 25, 2011 Dan Caplinger	Has Merck Become the Perfect Stock? Like most other pharma companies, Merck is dealing with the imminent loss of patent protection on one of its blockbuster drugs.
Chemistry World October 23, 2008 Matt Wilkinson	Merck to slash more jobs Beleaguered US pharma giant, Merck & Co., has announced new restructuring plans that will see the company cut 7,200 jobs in an effort to save up to $4.2 billion
The Motley Fool April 30, 2011 Brian Orelli	No Long-Term Guidance? No Problem! Looking good, Merck.
The Motley Fool January 23, 2006 Selena Maranjian	Money Making Money Put the snowball principle to work for your portfolio. But it is important to study dividend-paying candidates (and any stock you're considering, for that matter) carefully.
The Motley Fool December 22, 2006 Todd Wenning	Stocks That Pay You Back Supplement your income with these dividend-paying stocks: Pfizer... Merck... Procter & Gamble... Coca-Cola...
The Motley Fool February 17, 2005	What's a Dividend? A dividend is a portion of a company's earnings that the firm pays out to its shareholders.
The Motley Fool December 21, 2006 Brian Lawler	Dueling Fools: Merck Bull Rebuttal Plenty of cash. Big pipeline. Not to worry. The future can't be predicted, but Merck's history shows its ability to weather even the toughest pharmaceutical-development environments.
The Motley Fool April 15, 2011 Brian Orelli	Dark Clouds Lift Over Pharma Dispute The case of who bought whom in the Merck -Schering-Plough deal has ended in a draw.
The Motley Fool July 18, 2007 Ryan Fuhrmann	Pfizer Prepares for L-Day Will Pfizer be able to offset the looming loss of Lipitor? Investors, take note.
The Motley Fool December 19, 2005 Rick Aristotle Munarriz	4 Companies That Took a Hike Companies with growing yields can make you rich in more ways than the obvious: General Mills... Microsoft... Pfizer... T. Rowe Price...
The Motley Fool March 10, 2009 Selena Maranjian	2009: Will It Be the Worst Year Since 1958? Dividends are down, but don't write them off yet -- just proceed sensibly, and reap those profits!
The Motley Fool November 28, 2005 Stephen D. Simpson	Merck's Tighter Belt Bet Operational improvements are an expected move for Merck, but won't really improve long-term prospects. But investors must do their own due diligence to make their own calls here.
The Motley Fool October 21, 2004 Roger Nusbaum	Pictures of Lilly Eli Lilly's numbers get lost in the wake of Merck and Pfizer. While the market waits for drug stocks to recover, investors can collect Lilly's 2.5%, safe, dividend.
The Motley Fool February 24, 2011 Jordan DiPietro	Should You Retire With Merck? Is Merck a good choice for a retirement portfolio?
The Motley Fool June 30, 2011 Brian Orelli	Biotech Winners of a Repatriation Holiday Biotechs and dividend players will come out ahead.
The Motley Fool March 16, 2009 Dan Caplinger	The Wrong Stocks to Buy Right Now While the positive benefits of stocks that pay dividends are well-documented, recent experience paints a much different picture of their performance.
The Motley Fool June 27, 2008	What's a Dividend? Some companies repay your investment with cold, hard cash.
The Motley Fool May 21, 2009 Brian Orelli	Not So Fast, Schering ... er, Merck ... er, Whoever You Are Merck got cute with its acquisition of Schering-Plough by setting up the merger so that Schering is technically merging with Merck and then changing its name to Merck. That seemingly schizophrenic move had a purpose.
The Motley Fool May 19, 2009 Selena Maranjian	Frightening News About Dividend Stocks For dividend lovers, the past year has been brutal. Dividend cuts have come at the fastest pace in 50 or more years. Check out some of these not-so-obscure companies that have cut their dividend in the past 12 months.
The Motley Fool October 24, 2007 Selena Maranjian	Meet the Dividend Achievers If you're looking for dividend-paying stocks, you need to know the Mergent Dividend Achievers.
The Motley Fool June 14, 2006 Tim Hanson	The Market's 10 Most Mediocre Stocks Flat stocks may not always mean flat gains. AM Castle... Micron Technology... Valeant Pharmaceuticals... Progressive Gaming International... Horace Mann Educators... etc.
The Motley Fool April 5, 2010 Dan Caplinger	5 Stocks That Will Fatten Your Wallet Dividends are on the rise.
The Motley Fool December 21, 2006 Ryan Fuhrmann	Dueling Fools: Merck Bear Investors, because of its recent run-up, the risk/reward tradeoff is not very compelling. There are safer, more lucrative ways to invest in the space.
The Motley Fool July 10, 2006 Robert Brokamp	The Right Stocks for Retirement The question you've always asked is finally answered. But there's a lot more to retirement than simply picking up shares of high-yielding stocks.